Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

A new mouse model for vitiligo helps study immune responses and potential treatments.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Retinol may affect immune responses in people with frequent skin boils.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hair cortisol levels peak in the third trimester and decline postpartum.

Fetal skin has unique immune cells different from adult skin.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.